Literature DB >> 35991763

IgG4-associated autoimmune hepatitis and cholangitis: A relatively novel entity to consider in cases of seronegative autoimmune hepatitis.

Gabrielle Jutras1, Philip Wong2, José Ferreira3, Jean-Frederic Leblanc1.   

Abstract

A 49-year-old woman with no inflammatory bowel disease history presented to our clinic with abnormal liver function tests and right upper quadrant abdominal pain. Blood tests revealed a mixed pattern of liver injury. Abdominal magnetic resonance imaging demonstrated hepatomegaly with periportal edema and hyper-enhancing bile ducts without any sign of biliary obstruction or stricturing. Screening for viral hepatitis and autoimmune liver diseases was negative. An elevated immunoglobulin G (IgG) level suggested the possibility of autoimmune hepatitis (AIH), and a biopsy confirmed the presence of severe interface hepatitis with necrotic areas and focal lymphoid nodular formation. IgG4 staining revealed marked IgG4-positive plasma cell infiltration. A diagnosis of IgG4-associated seronegative AIH was made, and the patient was started on prednisone and azathioprine, with rapid resolution of the enzyme abnormalities. This clinical vignette highlights the potential challenges in establishing a diagnosis of IgG4-associated AIH and cholangitis, as demonstrated by the importance of confirmatory histopathology. Clinicians should maintain a high index of suspicion when confronted with a mixed pattern of liver injury with elevated immunoglobulins but seronegative autoimmune markers.
Copyright © 2021 Canadian Association for the Study of the Liver.

Entities:  

Keywords:  IgG4; autoimmune; hepatitis; hepatopathy

Year:  2021        PMID: 35991763      PMCID: PMC9204940          DOI: 10.3138/canlivj-2020-0023

Source DB:  PubMed          Journal:  Can Liver J        ISSN: 2561-4444


  17 in total

1.  IgG4 associated autoimmune hepatitis: a differential diagnosis for classical autoimmune hepatitis.

Authors:  T Umemura; Y Zen; H Hamano; T Ichijo; S Kawa; Y Nakanuma; K Kiyosawa
Journal:  Gut       Date:  2007-05-15       Impact factor: 23.059

Review 2.  Autoimmune hepatitis--Update 2015.

Authors:  Michael P Manns; Ansgar W Lohse; Diego Vergani
Journal:  J Hepatol       Date:  2015-04       Impact factor: 25.083

Review 3.  Autoantibody-negative autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2011-12-21       Impact factor: 3.199

Review 4.  Autoimmune hepatitis and immunoglobulin G4-associated autoimmune hepatitis.

Authors:  Norihisa Yada; Masatoshi Kudo; Hobyung Chung; Tomohiro Watanabe
Journal:  Dig Dis       Date:  2013-11-21       Impact factor: 2.404

5.  Histopathology of IgG4-Related Autoimmune Hepatitis and IgG4-Related Hepatopathy in IgG4-Related Disease.

Authors:  Yasuni Nakanuma; Yoji Ishizu; Yoh Zen; Kenichi Harada; Takeji Umemura
Journal:  Semin Liver Dis       Date:  2016-07-28       Impact factor: 6.115

6.  Evolution of autoimmune hepatitis to primary sclerosing cholangitis: A sequential syndrome.

Authors:  Ayman A Abdo; Vincent G Bain; Krikor Kichian; Samuel S Lee
Journal:  Hepatology       Date:  2002-12       Impact factor: 17.425

7.  Identification and characterization of IgG4-associated autoimmune hepatitis.

Authors:  Hobyung Chung; Tomohiro Watanabe; Masatoshi Kudo; Osamu Maenishi; Yoshio Wakatsuki; Tsutomu Chiba
Journal:  Liver Int       Date:  2009-07-24       Impact factor: 5.828

Review 8.  Grading and staging systems for inflammation and fibrosis in chronic liver diseases.

Authors:  Zachary D Goodman
Journal:  J Hepatol       Date:  2007-07-30       Impact factor: 25.083

9.  Clinical and histopathological features of immunoglobulin G4-associated autoimmune hepatitis in children.

Authors:  Yusuf Aydemir; Zuhal Akcoren; Hulya Demir; Inci Nur Saltik Temizel; Hasan Ozen; Aysel Yuce
Journal:  J Gastroenterol Hepatol       Date:  2018-11-14       Impact factor: 4.029

Review 10.  Autoimmune hepatitis and IgG4-related disease.

Authors:  Kosuke Minaga; Tomohiro Watanabe; Hobyung Chung; Masatoshi Kudo
Journal:  World J Gastroenterol       Date:  2019-05-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.